Suppr超能文献

乳酸脱氢酶与白蛋白比值作为COVID-19患者预后的预测因素;一项横断面研究。

Lactate Dehydrogenase to Albumin ratio as a Predictive Factor of COVID-19 Patients' Outcome; a Cross-sectional Study.

作者信息

Alizadeh Nafiseh, Tabatabaei Fatemeh-Sadat, Azimi Amirali, Faraji Neda, Akbarpour Samaneh, Dianatkhah Mehrnoush, Moghaddas Azadeh

机构信息

Department of Pharmaceutical Care, Baharlou Hospital, Tehran University of Medical Sciences, Tehran, Iran.

School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Arch Acad Emerg Med. 2022 Aug 15;10(1):e63. doi: 10.22037/aaem.v10i1.1646. eCollection 2022.

Abstract

INTRODUCTION

Despite the increasing vaccination coverage, COVID-19 is still a concern. With the limited health care capacity, early risk stratification is crucial to identify patients who should be prioritized for optimal management. The present study investigates whether on-admission lactate dehydrogenase to albumin ratio (LAR) can be used to predict COVID-19 outcomes.

METHODS

This retrospective cross-sectional study evaluated hospitalized COVID-19 patients in an academic referral center in Iran from May 2020 to October 2020. The area under the receiver operating characteristic (ROC) curve (AUC) was used to evaluate the value of LAR in the prediction of mortality. The Yuden index was used to find the optimal cut-off of LAR to distinguish severity. Patients were classified into three groups (LAR tertiles), first: LAR<101.46, second: 101.46≤LAR< 148.78, and third group: LAR≥148.78. Logistic regression analysis was used to identify the association between tertiles of LAR, as well as the relationship between each one-unit increase in LAR with mortality and ICU admission in three models, based on potential confounding variables.

RESULTS

A total of 477 patients were included. Among all patients, 100 patients (21%) died, and 121 patients (25.4%) were admitted to intensive care unit (ICU). In the third group, the risk of mortality and ICU admission increased 7.78 times (OR=7.78, CI: 3.95-15.26; p <0.0001) and 4.49 times (OR=4.49, CI: 2.01-9.04; p <0.0001), respectively, compared to the first group. The AUC of LAR for prediction of mortality was 0.768 (95% CI 0.69- 0.81). LAR ≥ 136, with the sensitivity and specificity of 72% (95%CI: 62.1-80.5) and 70% (95%CI: 64.9-74.4), respectively, was the optimal cut-off value for predicting mortality.

CONCLUSION

High LAR was associated with higher odds of COVID-19 mortality, ICU admission, and length of hospitalization. On-admission LAR levels might help health care workers identify critical patients early on.

摘要

引言

尽管疫苗接种覆盖率不断提高,但新冠病毒疾病(COVID-19)仍是一个令人担忧的问题。鉴于医疗保健能力有限,早期风险分层对于确定应优先进行最佳管理的患者至关重要。本研究调查入院时乳酸脱氢酶与白蛋白比值(LAR)是否可用于预测COVID-19的预后。

方法

这项回顾性横断面研究评估了2020年5月至2020年10月在伊朗一家学术转诊中心住院的COVID-19患者。采用受试者操作特征(ROC)曲线下面积(AUC)来评估LAR在预测死亡率方面的价值。使用尤登指数来确定区分严重程度的LAR最佳临界值。患者被分为三组(LAR三分位数),第一组:LAR<101.46,第二组:101.46≤LAR<148.78,第三组:LAR≥148.78。基于潜在混杂变量,在三个模型中使用逻辑回归分析来确定LAR三分位数之间的关联,以及LAR每增加一个单位与死亡率和入住重症监护病房(ICU)之间的关系。

结果

共纳入477例患者。在所有患者中,100例(21%)死亡,121例(25.4%)入住重症监护病房(ICU)。与第一组相比,第三组的死亡风险和入住ICU的风险分别增加了7.78倍(OR = 7.78,CI:3.95 - 15.26;p < 0.0001)和4.49倍(OR = 4.49,CI:2.01 - 9.04;p < 0.0001)。LAR预测死亡率的AUC为0.768(95%CI 0.69 - 0.81)。LAR≥136是预测死亡率的最佳临界值,其敏感性和特异性分别为72%(95%CI:62.1 - 80.5)和70%(95%CI:64.9 - 74.4)。

结论

高LAR与COVID-19死亡率、入住ICU的几率以及住院时间延长相关。入院时的LAR水平可能有助于医护人员早期识别重症患者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验